Scaling CRISPR Gene Correction for Sickle Cell Disease

• November 9, 2026

Increased Risk of Subsequent Cancers in Patients With Sézary Syndrome

• by Julia Nenonen, Despoina Tsakona, Philip Curman, Hanna Brauner

• October 26, 2026

Musings From the Power List: Jason Bock

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

• by Jason Bock

• October 14, 2026

• 14 min

Response to Zhou and Shan: Interpreting long-term response to rituximab in immune thrombocytopenia

• by Galina Tsykunova, Eskild Bendix Kristiansen, Tor Henrik Anderson Tvedt, Henrik Frederiksen, Christian Fynbo Christiansen, Marie Linder, Shahram Bahmanyar, Waleed Ghanima

• October 27, 2026